Organizing Committee

Nissim Benvenisty, MD, PhD
The Hebrew University of Jerusalem, Israel

Robert Blelloch, MD, PhD
University of California, San Francisco, USA

Daniel Marshak, PhD
Consulting & Advisory, USA

Melissa Carpenter, PhD
ElevateBio, USA

Assem Ziady, PhD
Cincinnati Children’s Hospital Medical Center, USA

John Tisdale, MD

Shen Shen, PhD
Vertex Pharmaceuticals, USA

Gerhard Bauer, Professor
University of California, School of Medicine, USA

IS Boston Web Banner

ISSCR 2022 Boston International Symposium

Join us for the ISSCR 2022 Boston International Symposium on Cell Manufacturing and Commercialization “Translating Pluripotent Stem Cell Discoveries to the Clinic: Preclinical, Manufacturing, and Regulatory Strategies for Success,” which will take place at the Boston Marriott Cambridge Boston, MA from 17-19 November 2022. 

The meeting will bring together international academic and commercial scientists with expertise in the preclinical, clinical, and regulatory phases to discuss the critical processes and strategies in the successful development of PSC-derived therapies. Sessions will cover some of the latest thinking and approaches for selecting the cell line, characterizing the product and manufacturing considerations, managing the immune system, and working with regulators throughout the process. We hope you can join us in one of the world’s hubs of biotechnology.


Keynote Speaker

Peter Marks_500x500


Peter Marks, MD, PhD
FDA Center for Biologics Evaluation and Research

Speakers & Topics

Preclinical Strategies
Doug Melton, PhD, Harvard University, USA
Su-Chun Zhang, MD, PhD, Duke-NUS Medical University, Singapore and University of Wisconsin-Madison, USA

Selecting Your Cell Line: Derivation and Characterization
Tenneille Ludwig, PhD, WiCell, USA
Nissim Benvenisty, PhD, Hebrew University Israel
Jennifer Dashnau, PhD, Century Therapeutics, USA

What’s in Your Product
Bahram (Bob) Valamehr, PhD, MBA, FATE Therapeutics, USA
Angela Keightley, PhD, BlueRock Therapeutics

New Technologies/Where Are We Going?
Daniel Paull, PhD, The New York Stem Cell Foundation (NYSCF)
Kapil Bharti, PhD, NIH, USA
Peter Zandstra, PhD, University of British Columbia, Canada

Immunology for Cell Therapies
George Daley, MD, PhD, Harvard University Medical School, USA
Sonja Schrepfer, MD, PhD, Sana Biotechnology, USA
Shin Kaneko, MD, PhD, CiRA, Kyoto University 

Balancing Science and Regulatory Requirements in Emerging Fields
Sponsored by: Cellino Biotech
Anthony Oro, MD, PhD, Stanford University, USA
Gesine Paul-Visse, MD, Lund University, Sweden
Melissa Carpenter, PhD, ElevateBio, USA

How to Accelerate with Accelerated Designations
Jane Lebkowski, PhD, Regenerative Patch Technologies, USA
Masayo Takahashi, MD, Vision Care, Inc, Japan

Delivering Your Cell Product: Strategies for Success
Cory R. Nicholas, PhD, Neurona Therapeutics, USA

What to Expect

The ISSCR has created our International Symposia to delve into current stem cell topics through exciting scientific programs in an engaging, intimate atmosphere.

Learn about the latest science from a slate of global speakers
Present your research in an abstract-selected talk or a poster presentation
Connect with colleagues through numerous networking opportunities


Poster Presentation Paris
Speaker Presentation Paris

Who Should Attend?

Academic, industry, and clinical researchers interested in stem cell biology and its therapeutic applications are encouraged to attend and share your latest research and findings. Attendees will hear from leaders in the field and benefit from the open exchange of ideas.



What Sets the International Symposia Apart?

ISSCR International Symposia are where the world's leading minds are building the future of stem cell science. They are focused meetings that bring together approximately 400 attendees, 100 poster presentations, and exhibitors with innovative technologies. The goal is to expand ISSCR's educational reach, making it more accessible for stem cell scientists in regions around the world.

Arc de Triomphe Paris